You are here

Home » Content

TUBEROZ SKLEROZ KOMPLEKSİ

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 1998

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Tuberous sclerosis complex is a hamartamatosis which mainly effects central nervous system, skin, kidney, liver and heart. The predominant neurologic manifestations are seizure and mental retardation. A 39-year-old female patient with late onset seizure and typical skin findings and her sons are presented and this clinical entity 13 reviewed with are emphasis on the importance of systemic family screening.
Bookmark/Search this post with
Abstract (Original Language): 
Tuberoz skleroz kompleksi, başlıca santral sinir sistemi, deri, böbrek, karaciğer ve kalbi etkileyen hamartomatoz bir hastalıktır. En belirgin nörolojik özellik nöbet ve mental retardasyondur. Geç başlangıçlı nöbet ve tipik deri bulguları olan 39 yaşında bir bayan hasta ve aile taraması sonucu tanı konulan iki oğlu, tüm ailenin sistemik taramasının önemini vurgulamak amacıyla sunulmuştur.
FULL TEXT (PDF): 
PDF icon arastirmax-tuberoz-skleroz-kompleksi.pdf
  • 4
198-202
  • Turkish

REFERENCES

References: 

1. European chromosome 16 Tuberous Sclerosis Consortium. Identification and charcterization of the tuberous sclerosis gene 16. Cell 1993; 75: 1305-1315.
2. Fryer AE, Connor JM, Povey S et al. Evidence that gene for tuberous sclerosis in chromosome 9. Lancet 1987; 1: 659-666.
3. Gomez MR, Kuntz NL, Westmoreland BF. Tuberous sclerosis, early onset of seizures and mental subabnormality study of discordant homozygots twins. Neurology 1982; 32: 604.
4. Gomez MR, Rafecas JC, Houser OW. The diagnostic and prognostic significance of low attenuation lesions in the head computed tomography scan of patients with tuberous sclerosis. Ann Neurol 1987; 22: 419. (Abstract)
5. Gomez MR. Neurocutaneous Disease. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (Eds.) Neurology in Clinical Practice. 2nd Edition, Volume II, Butterworth Heinemann 1996; 1566-1571.
6. Goodman M, Lamin SH, Engel A, et al. Cortical tuber count: a bio-marker indicating severity of tuberous sclerosis complex. J Child Neurol 1997; 12: 85-90.
7. Hanno R, Beck R. Tuberous Sclerosis. Neurologic Clinics 1987; 5: 351-359.
8. Jozwiak S, Goodman M, Lamm SH. Poor mental development in patients with Tuberous Sclerosis Complex. Clinical risk factors. Arch Neurol 1998; 55: 379-384.
9. Kingsley DPE, Kendall BE, Fitz CR. Tuberous Sclerosis: A clinicoradiologic evaluation of 110 cases with particular reference to atypical presentation. Neuroradiology 1986; 28: 38-46.
10. Laster DW. Magnetic resonance imaging in Tuberous Sclerosis. Arch Neurol 1987; 44: 301-303.
11. Nagib MG, Haines SJ, Erickson DL, et al. Tuberous Slerosis: A review for the neurosurgeon. Neurosurgery 1984; 14: 93-98.
12. Pampiglione G, Moynahan EJ. The Tuberous sclerosis syndrome: Clinical and EEG Studies in 100 Children. J Neurol Neurosurg Psychiatry 1976; 666-673.
13. Roach ES, Smith M, Hutlenlocher P. Diagnostic criteria tuberous sclerosis complex: report of Diagnostic Criteria Committe of National Tuberous Sclerosis Association. J Child Neurology l992; 7: 221-224.
14. Shephard CW, Houser OW, Gomez MR. MR findings in tuberous sclerosis complex and carrelation with seizure development and mental impairment. AJNR 1995; 16: 149-155.

Thank you for copying data from http://www.arastirmax.com